CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4732) Cancer Therapeutics (1137)
Siamab Therapeutics is a biopharmaceutical company developing cancer immunotherapies. Siamab has developed a platform of technologies that enable the discovery and development of therapeutic antibodies that bind to a class of carbohydrate antigens pr...Show all
Company (Alive / Active)
Phone: 617-714-9773
90 Bridge Street
Suite 100
Newton, 02458
Massachusetts, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | Boston Harbor Angels |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Glycan-interacting compounds and methods of use | Jan 04, 2016 | Jan 30, 2018 | Patent |
| Compositions and methods for detecting cancer | Dec 23, 2013 | Aug 23, 2016 | Patent |
| Glycan-interacting compounds | Jan 21, 2016 | Aug 16, 2016 | Patent |
| Glycan-interacting compounds | Oct 10, 2013 | Mar 01, 2016 | Patent |
| Glycan-interacting compounds | Jul 11, 2016 | Application |
Download PDF